Intuitive 的预测超出了预期，手术数量的反弹推动了对其机器人的需求。 Intuitive beats estimates that a rebound in surgeries boosts demand for its robots.

由于手术复苏提振了对其微创机器人的需求，Intuitive Surgical 的第四季度收入和利润超出了华尔街的预期。 Intuitive Surgical beat Wall Street estimates for fourth-quarter revenue and profit, as a recovery in surgeries lifted demand for its minimally invasive robots. 医疗器械制造商已经注意到减肥药物对腹部手术产品销售的暂时影响。 Medical device makers have noted the temporary impact of weight-loss drugs on sales of abdomen surgery products. Intuitive 股价在盘后交易中上涨 7.2%，至 399 美元。 Shares of Intuitive rose 7.2% to $399 in extended trading. 强生公司预计 2024 年医疗技术相关手术将继续保持较高水平。 Johnson & Johnson expects medtech-related procedures to remain elevated in 2024.